Exane Derivatives’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Exane Derivatives's VRTX Position: Q2 2022 in Review
Exane Derivatives sold out of Vertex Pharmaceuticals (VRTX) in Q2 2022, closing a stake of 3,109 shares — an estimated $811K sold.
Exane Derivatives first reported a position in VRTX in Q4 2014 and held it in 26 quarters. The position peaked at $23.6M in Q4 2014. 1,106 funds tracked by Wall St. Rank hold VRTX as of Q2 2022.
- Exane Derivatives reported no remaining Vertex Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
- Exane Derivatives sold 3,109 Vertex Pharmaceuticals shares in Q2 2022, an estimated $811K.
- Exane Derivatives first reported a position in Vertex Pharmaceuticals in Q4 2014 and held it in 26 quarters.
- Exane Derivatives's Vertex Pharmaceuticals position peaked at $23.6M in Q4 2014.
- 1,106 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2022.
Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.